IN THE MATTER OF the Patent Act R.S.C. 1985, c. P-4,
as amended
AND IN THE MATTER OF Galderma Canada Inc.
(the “Respondent”)

TAKE NOTICE that the Patented Medicine Prices Review Board (the “Board”) will hold a hearing in its offices in the Standard Life Centre, 333 Laurier Avenue West, 18th Floor, Ottawa, Ontario, on a date to be determined by the Hearing Panel.

The purpose of this proceeding is to receive the evidence and argument of the Staff of the Board (“Board Staff”) and Galderma Canada Inc. (the “Respondent”) on the Application by Board Staff dated January 19, 2016, for an Order, under section 81 of the Patent Act, requiring the Respondent to provide the Board with the information and documents referred to in section 80 of the Act and in sections 3 and 4 of the Patented Medicines Regulations.

Persons wishing to intervene in the proceeding are required to apply to the Board for leave to intervene on or before April 4, 2016. Such persons should contact the Secretary of the Board for further information on the procedure.

All requests for information should be addressed to the Secretary of the Board, Standard Life Centre, Suite 1400, 333 Laurier Avenue West, Ottawa, Ontario K1P 1C1; 1 877 861-2350 (Toll-free number); (613) 954-8299 (Direct line); (E-mail).

Date modified: